Detalhe da pesquisa
1.
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study.
Euro Surveill
; 28(3)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695484
2.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
3.
Distinct and separable roles for endogenous CRY1 and CRY2 within the circadian molecular clockwork of the suprachiasmatic nucleus, as revealed by the Fbxl3(Afh) mutation.
J Neurosci
; 33(17): 7145-53, 2013 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23616524
4.
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Lancet Reg Health Eur
; 37: 100816, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162515
5.
Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts.
Nat Commun
; 15(1): 2363, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491011
6.
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
J Infect
; 88(4): 106129, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431156
7.
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
Lancet Reg Health Eur
; 32: 100681, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671127
8.
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study.
J R Soc Med
; : 1410768231205430, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921538
9.
Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom.
JMIR Form Res
; 6(8): e37821, 2022 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35786634
10.
Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool.
JMIR Res Protoc
; 10(5): e29072, 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939619
11.
An Early Warning Risk Prediction Tool (RECAP-V1) for Patients Diagnosed With COVID-19: Protocol for a Statistical Analysis Plan.
JMIR Res Protoc
; 10(10): e30083, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468322
12.
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
J Alzheimers Dis
; 74(1): 213-225, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985466
13.
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result.
Front Aging Neurosci
; 10: 409, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30618716
14.
Generation of mouse mutants as tools in dissecting the molecular clock.
Prog Brain Res
; 199: 247-265, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22877670